1. Home
  2. AVLN vs SBET Comparison

AVLN vs SBET Comparison

Compare AVLN & SBET Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Avalyn Pharma Inc. Common Stock

AVLN

Avalyn Pharma Inc. Common Stock

N/A

Current Price

$27.52

Market Cap

1.3B

Sector

Health Care

ML Signal

N/A

Logo SharpLink Gaming Ltd.

SBET

SharpLink Gaming Ltd.

N/A

Current Price

$9.55

Market Cap

1.4B

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
AVLN
SBET
Founded
2011
1995
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.4B
IPO Year
2026
2025

Fundamental Metrics

Financial Performance
Metric
AVLN
SBET
Price
$27.52
$9.55
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
8
Target Price
★ $62.25
$16.63
AVG Volume (30 Days)
192.8K
★ 7.5M
Earning Date
08-12-2026
11-11-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
★ $28,055,000.00
Revenue This Year
N/A
$62.83
Revenue Next Year
N/A
$74.42
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ 666.04
52 Week Low
$24.90
$4.46
52 Week High
$40.17
$19.53

Technical Indicators

Market Signals
Indicator
AVLN
SBET
Relative Strength Index (RSI) 35.91 58.27
Support Level $25.86 $8.69
Resistance Level $30.45 $10.44
Average True Range (ATR) 2.25 0.51
MACD -0.56 -0.06
Stochastic Oscillator 14.12 65.38

Price Performance

Historical Comparison
AVLN
SBET

About AVLN Avalyn Pharma Inc. Common Stock

Avalyn Pharma Inc is a clinical-stage biopharmaceutical company developing inhaled medicines to treat rare respiratory diseases, including pulmonary fibrosis and other interstitial lung diseases (ILDs). Its current pipeline is focused on treating pulmonary fibrosis, a life-threatening disease with a median survival of three to five years, which is a significantly shorter prognosis than that observed for many forms of cancer. Its flagship programs include AP01 and AP02, which are inhaled formulations of pirfenidone and nintedanib being developed for conditions such as progressive pulmonary fibrosis and idiopathic pulmonary fibrosis. The company has one operating and reportable segment, which is the business of developing and commercializing targeted therapies for rare lung diseases.

About SBET SharpLink Gaming Ltd.

Sharplink Inc is one of those publicly traded companies to adopt ETH as its primary treasury reserve asset. This move reflects the Company's commitment to align corporate treasury with the future of programmable finance, digital capital markets, and decentralized infrastructure. The Company also operates an online affiliate marketing company that delivers different fan activation solutions to its sportsbook and online casino gaming partners. The company operates in two reportable segments: ETH Treasury Management and Affiliate Marketing. The majority of its revenue is generated from the ETH Treasury Management. Geographically, the company operates in the United States and the rest of the world.

Share on Social Networks: